$45.30
arrow_drop_up0.63%Key Stats | |
---|---|
Open | $45.36 |
Prev. Close | $45.02 |
EPS | -0.95 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 45.03 | 46.02 |
52 Week Range | 7.60 | 47.55 |
Ratios | |
---|---|
EPS | -0.95 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Nicox announces attendance at upcoming conferences - GlobeNewswire
Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
Insiders Buying Greenwich LifeSciences And 2 Other Stocks
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket